L. Gamberoni

470 total citations
8 papers, 400 citations indexed

About

L. Gamberoni is a scholar working on Molecular Biology, Cell Biology and Spectroscopy. According to data from OpenAlex, L. Gamberoni has authored 8 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Cell Biology and 2 papers in Spectroscopy. Recurrent topics in L. Gamberoni's work include Enzyme Catalysis and Immobilization (2 papers), Microbial Metabolic Engineering and Bioproduction (2 papers) and Protein Interaction Studies and Fluorescence Analysis (2 papers). L. Gamberoni is often cited by papers focused on Enzyme Catalysis and Immobilization (2 papers), Microbial Metabolic Engineering and Bioproduction (2 papers) and Protein Interaction Studies and Fluorescence Analysis (2 papers). L. Gamberoni collaborates with scholars based in Italy and Japan. L. Gamberoni's co-authors include M. Carini, Giancarlo Aldini, Roberto Maffei Facino, Giulio Vistoli, Luca Regazzoni, Kôji Uchida, Marica Orioli, Isabella Dalle‐Donne, Aldo Milzani and Giangiacomo Beretta and has published in prestigious journals such as Biochemistry, Free Radical Biology and Medicine and Chemical Research in Toxicology.

In The Last Decade

L. Gamberoni

8 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Gamberoni Italy 7 226 83 77 65 51 8 400
Marianne E. Staretz United States 10 196 0.9× 39 0.5× 74 1.0× 26 0.4× 29 0.6× 16 406
Peter J. O'Brien Canada 8 196 0.9× 70 0.8× 102 1.3× 85 1.3× 23 0.5× 10 553
Steven R. Tannenbaum United States 8 274 1.2× 222 2.7× 60 0.8× 53 0.8× 57 1.1× 9 678
Michelle V. Williams United States 12 404 1.8× 73 0.9× 66 0.9× 51 0.8× 131 2.6× 14 729
Jacques Alary Morocco 5 167 0.7× 52 0.6× 97 1.3× 140 2.2× 21 0.4× 5 351
Laurie L. McLeod United States 8 240 1.1× 71 0.9× 60 0.8× 123 1.9× 14 0.3× 8 511
Soumya Sasi United States 11 378 1.7× 70 0.8× 81 1.1× 46 0.7× 7 0.1× 12 593
David M. Guido United States 12 180 0.8× 77 0.9× 35 0.5× 36 0.6× 40 0.8× 14 456
Gordon F. Fairclough United States 8 217 1.0× 40 0.5× 55 0.7× 135 2.1× 49 1.0× 12 550
Guifen Xu United States 14 184 0.8× 26 0.3× 72 0.9× 33 0.5× 28 0.5× 25 454

Countries citing papers authored by L. Gamberoni

Since Specialization
Citations

This map shows the geographic impact of L. Gamberoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Gamberoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Gamberoni more than expected).

Fields of papers citing papers by L. Gamberoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Gamberoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Gamberoni. The network helps show where L. Gamberoni may publish in the future.

Co-authorship network of co-authors of L. Gamberoni

This figure shows the co-authorship network connecting the top 25 collaborators of L. Gamberoni. A scholar is included among the top collaborators of L. Gamberoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Gamberoni. L. Gamberoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Orioli, Marica, Giulio Vistoli, Luca Regazzoni, et al.. (2011). Design, Synthesis, ADME Properties, and Pharmacological Activities of β‐Alanyl‐D‐histidine (D‐Carnosine) Prodrugs with Improved Bioavailability. ChemMedChem. 6(7). 1269–1282. 38 indexed citations
2.
Aldini, Giancarlo, Giulio Vistoli, Luca Regazzoni, et al.. (2008). Albumin Is the Main Nucleophilic Target of Human Plasma: A Protective Role Against Pro-atherogenic Electrophilic Reactive Carbonyl Species?. Chemical Research in Toxicology. 21(4). 824–835. 92 indexed citations
4.
Aldini, Giancarlo, Luca Regazzoni, L. Gamberoni, & M. Carini. (2007). A TANDEM MS PRECURSOR-ION SCAN APPROACH FOR THE IDENTIFICATION OF VARIABLE COVALENT MODIFICATION OF ALBUMIN CYS34 TO STUDY VASCULAR CARBONYLATION. 1 indexed citations
5.
Dalle‐Donne, Isabella, M. Carini, Giulio Vistoli, et al.. (2006). Actin Cys374 as a nucleophilic target of α,β-unsaturated aldehydes. Free Radical Biology and Medicine. 42(5). 583–598. 75 indexed citations
6.
Aldini, Giancarlo, L. Gamberoni, Marica Orioli, et al.. (2006). Mass spectrometric characterization of covalent modification of human serum albumin by 4‐hydroxy‐trans‐2‐nonenal. Journal of Mass Spectrometry. 41(9). 1149–1161. 99 indexed citations
7.
Santaniello, Enzo, Silvana Casati, Pierangela Ciuffreda, & L. Gamberoni. (2005). Lipase-catalyzed alcoholysis of diol dibenzoates: selective enzymatic access to the 2-benzoyl ester of 1,2-propanediol and preparation of the enantiomerically pure (R)-1-O-benzoyl-2-methylpropane-1,3-diol. Tetrahedron Asymmetry. 16(9). 1705–1708. 15 indexed citations
8.
Santaniello, Enzo, Silvana Casati, Pierangela Ciuffreda, & L. Gamberoni. (2004). Asymmetrization of 2-methylpropane-1,3-diol by Mucor miehei lipase-catalyzed benzoylation in organic solvent. Tetrahedron Asymmetry. 15(20). 3177–3179. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026